Prevalence of the BRCA1 Founder Mutation C.5266dupin Brazilian Individuals At-Risk for the Hereditary Breast and Ovarian Cancer Syndrome

Hereditary Cancer in Clinical Practice - United Kingdom
doi 10.1186/1897-4287-9-12
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Founder BRCA1/2 Mutations in the Europe: Implications for Hereditary Breast-Ovarian Cancer Prevention and Control

EPMA Journal
BiochemistryHealth PolicyDrug Discovery
2010English

The RAD51 135 G>C Polymorphism Modifies Breast Cancer and Ovarian Cancer Risk in Polish BRCA1 Mutation Carriers

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2007English

Hereditary Breast and Ovarian Cancer Syndrome

Klinicka Onkologie
Oncology
2016English

Risk Assessment for Hereditary Breast Cancer: BRCA1 and BRCA2

Canadian Oncology Nursing Journal
2010English

High Prevalence of a BRCA1 Gene Founder Mutation, 5083del19, in Unselected Breast–ovarian Cancer Patients From Southern Italy: Genotype–phenotype Correlations

Breast Cancer Research
Cancer ResearchOncology
2005English

Hereditary Breast-Ovarian Cancer Syndrome in Russia

Acta Naturae
BiochemistryBiotechnologyMolecular MedicineMolecular Biology
2010English

Analysis of Clinical Characteristics of Breast Cancer Patients With the Japanese Founder Mutation BRCA1 L63X

Oncotarget
Oncology
2019English

Hereditary Breast Cancer in Moroccan Populations: BRCA1 & BRCA2 at the Glance

Journal of Genetic Syndromes & Gene Therapy
2014English

Carrier Risk Status Changes Resulting From Mutation Testing in Hereditary Non-Polyposis Colorectal Cancer and Hereditary Breast-Ovarian Cancer

Journal of Medical Genetics
Genetics
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy